Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cosetta Ravelli

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|November 16, 2013
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlinMichela Corsini, Emanuela Moroni, Cosetta Ravelli, et al.
Angiogenesis|August 1, 2019
VEGFR2 activation mediates the pro-angiogenic activity of BMP4Sara Rezzola, Margherita Di Somma, Michela Corsini, et al.
Vascular Pharmacology|May 29, 2016
Vascular disrupting activity of combretastatin analoguesElena Porcù, Alessia Salvador, Irina Primac, et al.
Biochimica Et Biophysica Acta. General Subjects|October 1, 2023
The D647N mutation of FGFR1 induces ligand-independent receptor activationMattia Domenichini, Cosetta Ravelli, Michela Corsini, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|November 25, 2019
Molecular insight on the altered membrane trafficking of TrkA kinase dead mutantsRosy Amodeo, Riccardo Nifosì, Chiara Giacomelli, et al.
Cell Death & Disease|January 14, 2026
Aberrant VEGFR2 supports tumor growth by extracellular matrix remodelingMichela Corsini, Cosetta Ravelli, Mattia Domenichini, et al.
ACS Omega|November 24, 2025
A Glucosylated BODIPY Uses the GLUT Channel to Target Cancer Cells in <i>In Vitro</i> and <i>In Vivo</i> ModelsMarta Turati, Giacomo Biagiotti, Cosetta Ravelli, et al.
Molecular Cancer Therapeutics|October 17, 2013
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cellsRoberto Ronca, Emanuela Di Salle, Arianna Giacomini, et al.
Cancers|June 2, 2021
Pentraxin 3 Inhibits the Angiogenic Potential of Multiple Myeloma CellsRoberto Ronca, Sara Taranto, Michela Corsini, et al.
Oncotarget|May 14, 2016
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonistElisabetta Grillo, Cosetta Ravelli, Michela Corsini, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Arteriosclerosis, Thrombosis, and Vascular Biology|November 16, 2013
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlinMichela Corsini, Emanuela Moroni, Cosetta Ravelli, et al.
Angiogenesis|August 1, 2019
VEGFR2 activation mediates the pro-angiogenic activity of BMP4Sara Rezzola, Margherita Di Somma, Michela Corsini, et al.
Vascular Pharmacology|May 29, 2016
Vascular disrupting activity of combretastatin analoguesElena Porcù, Alessia Salvador, Irina Primac, et al.
Biochimica Et Biophysica Acta. General Subjects|October 1, 2023
The D647N mutation of FGFR1 induces ligand-independent receptor activationMattia Domenichini, Cosetta Ravelli, Michela Corsini, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|November 25, 2019
Molecular insight on the altered membrane trafficking of TrkA kinase dead mutantsRosy Amodeo, Riccardo Nifosì, Chiara Giacomelli, et al.
Cell Death & Disease|January 14, 2026
Aberrant VEGFR2 supports tumor growth by extracellular matrix remodelingMichela Corsini, Cosetta Ravelli, Mattia Domenichini, et al.
ACS Omega|November 24, 2025
A Glucosylated BODIPY Uses the GLUT Channel to Target Cancer Cells in <i>In Vitro</i> and <i>In Vivo</i> ModelsMarta Turati, Giacomo Biagiotti, Cosetta Ravelli, et al.
Molecular Cancer Therapeutics|October 17, 2013
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cellsRoberto Ronca, Emanuela Di Salle, Arianna Giacomini, et al.
Cancers|June 2, 2021
Pentraxin 3 Inhibits the Angiogenic Potential of Multiple Myeloma CellsRoberto Ronca, Sara Taranto, Michela Corsini, et al.
Oncotarget|May 14, 2016
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonistElisabetta Grillo, Cosetta Ravelli, Michela Corsini, et al.
Pageof 5